<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?DTDIdentifier.IdentifierValue article.dtd?><?DTDIdentifier.IdentifierType system?><?SourceDTD.DTDName article.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName bmc2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Cancer Imaging</journal-id><journal-id journal-id-type="iso-abbrev">Cancer Imaging</journal-id><journal-title-group><journal-title>Cancer Imaging</journal-title></journal-title-group><issn pub-type="ppub">1740-5025</issn><issn pub-type="epub">1470-7330</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1470-7330-14-S1-S11</article-id><article-id pub-id-type="doi">10.1186/1470-7330-14-S1-S11</article-id><article-categories><subj-group subj-group-type="heading"><subject>Scientific Session Presentation</subject></subj-group></article-categories><title-group><article-title>Multiparametrical diffusion weighted imaging for the detection of anaplastic transformation of low-grade gliomas</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Freitag</surname><given-names>MT</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>m.freitag@dkfz.de</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Weber</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Maier-Hein</surname><given-names>K</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Tarnawski</surname><given-names>R</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Bobek-Billewicz</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Binczyck</surname><given-names>F</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A7"><name><surname>Polanska</surname><given-names>J</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib><contrib contrib-type="author" id="A8"><name><surname>Stieltjes</surname><given-names>B</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>German Cancer Research Center, Quantitative Imaging-based Disease Characterization, Department of Radiology, Heidelberg, Germany</aff><aff id="I2"><label>2</label>German Cancer Research Center, Department of Medical Informatics, Heidelberg, Germany</aff><aff id="I3"><label>3</label>Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Poland</aff><aff id="I4"><label>4</label>Silesian University of Technology, Data Mining Group, Gliwice, Poland</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>9</day><month>10</month><year>2014</year></pub-date><volume>14</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</named-content><named-content content-type="supplement-sponsor">Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens AG, Healthcare Sector, Imaging and Therapy Division.</named-content></supplement><fpage>S11</fpage><lpage>S11</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Freitag et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Freitag et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.cancerimagingjournal.com/content/14/S1/S11"/><conference><conf-date>9-11 October 2014</conf-date><conf-name>International Cancer Imaging Society (ICIS) 14th Annual Teaching Course</conf-name><conf-loc>Heidelberg, Germany</conf-loc></conference></article-meta></front><body><sec><title>Aim</title><p>The precise detection of anaplastic transformation in low-grade gliomas using magnetic resonance imaging (MRI) is impeded by postoperative changes in brain tissue. We tested the diagnostic value of diffusion tensor-derived axial diffusivity (AD), mean diffusivity (MD) (=apparent diffusion coefficient) and radial diffusivity (RD) maps in comparison to T1w and T2w sequences.</p></sec><sec sec-type="methods"><title>Methods</title><p>The study was approved by the local ethics committee. Forty-seven patients with histopathologically proven low-grade glioma II&#x000b0; were included, 28 were stable and 19 patients had post-surgical anaplastic transformation. All patients underwent pre-operative MRI, surgery and subsequent post-operative MRI follow-ups at 1.5T including T1w, T2w sequences and a DTI-protocol. The scalar indices AD, MD and RD were calculated voxel-by- voxel for all patients from the tensor eigenvalues and the minimum value within a gross tumour segmentation was extracted using MITK-Diffusion, respectively.</p></sec><sec sec-type="results"><title>Results</title><p>Hypointense clusters were seen in every patient with anaplastic transformation in the DTI maps with best contrast-to-noise in AD. In 65% of patients with anaplastic transformation, these clusters were noticed at the same time when compared to contrast enhancement. In 35% of patients, hypointense changes were visible in AD maps in examinations prior to the initial contrast enhancement. ADmin showed best combined sensitivity/specificity (94.4%/89.7%, AUC 0.96) to indicate transformation.</p></sec><sec sec-type="conclusions"><title>Conclusion</title><p>AD maps provide additional essential information for anaplastic transformation of low-grade gliomas after resection and indicate the progress at the same time or earlier when compared to T1w-CE. We conclude that it is advisable to use a DTI-protocol instead of standard diffusion-weighted imaging for neuro-oncological exams.</p></sec></body></article>
